Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Clayburgh

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A Mascarella, Tolani F Olonisakin, Purva Rumde, et al.
Cell Reports|April 6, 2017
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor PrognosisTakahiro Tsujikawa, Sushil Kumar, Rohan N Borkar, et al.
Scientific Reports|July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumorsMatthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 3, 2023
Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival BenefitMarco A Mascarella, Tolani F Olonisakin, Purva Rumde, et al.
Cell Reports|April 6, 2017
Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor PrognosisTakahiro Tsujikawa, Sushil Kumar, Rohan N Borkar, et al.
Scientific Reports|July 2, 2021
Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumorsMatthew S Dietz, Thomas L Sutton, Brett S Walker, et al.
Pageof 5